Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Staged Interventions to Improve Quality and Reduce Cost of Care in Patients with Suspected Heparin-Induced Thrombocytopenia

Bethany T Samuelson, MD, Meredith Holmes, PharmD, Andrew White, MD, Emily Glynn, MD, Daniel B Martin, MD, David Garcia, MD, Janet Kelly, PharmD, Ann Kathryn Wittkowsky, PharmD

Blood (2015) 126 (23): 2262.

https://doi.org/10.1182/blood.V126.23.2262.2262

Published: 2015

Journal Articles

SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature.

Francesco Dentali, MD, Chiara Marchesi, Matteo Giorgi Pierfranceschi, Mark A. Crowther, MD, FRCPC, David Garcia, MD, Elaine M. Hylek, MD, MPH, Dan Witt, Nathan Clark, Alessandro Squizzato, Davide Imberti, Walter Ageno

Blood (2010) 116 (21): 1113.

https://doi.org/10.1182/blood.V116.21.1113.1113

Published: 2010

Journal Articles

Results of the EmbraceAC Trial: A Head-to-Head Comparison of Warfarin with Tecarfarin, A New Anticoagulant.

David Garcia, MD, Peter G Milner, MD, FACC, Daniel M Canafax, Pharm, D, David J Ellis, MD, Ph.D.

Blood (2009) 114 (22): 3135.

https://doi.org/10.1182/blood.V114.22.3135.3135

Published: 2009

Journal Articles

Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study

Francesco Dentali, MD, Walter Ageno, Dan Witt, Alessandra Malato, Nathan Clark, II, David Garcia, MD, Sergio Siragusa, MD, Kathleen McCool, Shannon Dyke, Mark A. Crowther, MD

Blood (2008) 112 (11): 3027.

https://doi.org/10.1182/blood.V112.11.3027.3027

Published: 2008

Journal Articles

Risk of Thromboembolism after Short-Term Interruption of Warfarin.

David Garcia, MD, Elaine Hylek, MD

Blood (2006) 108 (11): 625.

https://doi.org/10.1182/blood.V108.11.625.625

Published: 2006

Journal Articles

Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0.

Mark A. Crowther, MD, MSc, David Garcia, MD, Walter Ageno, MD, Daniel M. Witt, PharmD, Sam Schulman, MD, Mark Blostein, MD, Michael J. Kovacs, MD, Clive Kearon, MD, PhD, David Anderson, MD, MSc, Phil Wells, MD, MSc, Jeff S. Ginsberg, MD, Rita Selby, MD, MSc, Luqi Wang, PhD, Susan R. Kahn, MD, MSc

Blood (2005) 106 (11): 547.

https://doi.org/10.1182/blood.V106.11.547.547

Published: 2005

NARROW

Staged Interventions to Improve Quality and Reduce Cost of Care in Patients with Suspected Heparin-Induced Thrombocytopenia

SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature.

Results of the EmbraceAC Trial: A Head-to-Head Comparison of Warfarin with Tecarfarin, A New Anticoagulant.

Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study

Risk of Thromboembolism after Short-Term Interruption of Warfarin.

Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0.

Email alerts

ASH Publications

American Society of Hematology

Staged Interventions to Improve Quality and Reduce Cost of Care in Patients with Suspected Heparin-Induced Thrombocytopenia

SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature.

Results of the EmbraceAC Trial: A Head-to-Head Comparison of Warfarin with Tecarfarin, A New Anticoagulant.

Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study

Risk of Thromboembolism after Short-Term Interruption of Warfarin.

Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only